Literature DB >> 1309556

Studies of CD4- CD8- alpha beta bone marrow T cells with suppressor activity.

V Palathumpat1, S Dejbakhsh-Jones, B Holm, H Wang, O Liang, S Strober.   

Abstract

The predominant T cell subset in the bone marrow of specific pathogen-free C57BL/Ka and BALB/c mice expressed the alpha beta+ TCR CD4- CD8- surface phenotype. Purified C57BL/Ka alpha beta+ TCR CD4- CD8- marrow cells obtained by cell sorting suppressed the MLR of C57BL/Ka responder and BALB/c stimulator spleen cells. Although the percentage of typical T cells in the spleen was markedly reduced in adult nude mice or normal neonatal mice as compared to the normal adult, the percentage of alpha beta+ TCR CD4- CD8- cells in the spleen and marrow was not. The percentage of "self-reactive" V beta 5+ T cells in the BALB/c spleen was markedly reduced as compared to that in the C57BL/Ka spleen. However, the percentages in the bone marrow were similar. The results indicate that the predominant subset of marrow T cells in these pathogen-free mice differ with regard to surface marker phenotype, function, dependence on the adult thymus, and deletion of certain self-reactive V beta receptors as compared to typical spleen T cells. The marrow T cells appear to develop directly from marrow precursors without rearranged beta chain genes during a 48 hour in vitro culture.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309556

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Identification of an early T cell progenitor for a pathway of T cell maturation in the bone marrow.

Authors:  S Dejbakhsh-Jones; S Strober
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

Review 2.  NKT cells, Treg, and their interactions in bone marrow transplantation.

Authors:  Holbrook E Kohrt; Asha B Pillai; Robert Lowsky; Samuel Strober
Journal:  Eur J Immunol       Date:  2010-07       Impact factor: 5.532

Review 3.  Application of natural killer T-cells to posttransplantation immunotherapy.

Authors:  Shin-ichiro Fujii
Journal:  Int J Hematol       Date:  2005-01       Impact factor: 2.490

4.  The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients.

Authors:  R Garcia-Morales; M Carreno; J Mathew; K Zucker; R Cirocco; G Ciancio; G Burke; D Roth; D Temple; A Rosen; L Fuller; V Esquenazi; T Karatzas; C Ricordi; A Tzakis; J Miller
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

5.  Interleukin-12 induces cytotoxic NK1+ alpha beta T cells in the lungs of euthymic and athymic mice.

Authors:  R Anzai; S Seki; K Ogasawara; W Hashimoto; K Sugiura; M Sato; K Kumagai; K Takeda
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

6.  A murine retrovirus induces proliferation of unique lymphoid cell lines expressing T-cell-receptor structures utilizing common variable region alpha and beta chain genes.

Authors:  H C O'Neill
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

7.  Human CD4-CD8- alpha beta + T-cell receptor T cells recognize different mycobacteria strains in the context of CD1b.

Authors:  H Thomssen; J Ivanyi; C Espitia; A Arya; M Londei
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

8.  Effect of recombinant human granulocyte colony-stimulating factor on T-lymphocyte function and the mechanism of this effect.

Authors:  Song-He Chen; Xin Li; Xiao-Jun Huang
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

9.  Intrathyroidal lymphocyte subsets, including unusual CD4+ CD8+ cells and CD3loTCR alpha beta lo/-CD4-CD8- cells, in autoimmune thyroid disease.

Authors:  Y Iwatani; Y Hidaka; F Matsuzuka; K Kuma; N Amino
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

10.  Characterization of intermediate T-cell receptor cells expanding in the liver, thymus and other organs in autoimmune lpr mice: parallel analysis with their normal counterparts.

Authors:  T Iiai; M Kimura; Y Kawachi; K Hirokawa; H Watanabe; K Hatakeyama; T Abo
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.